Analysis of more than 14,000 admissions of malnourished children in Chad found that the low cost RISQ severity scoring tool helped healthcare workers identify severely ill children earlier, leading to fewer deaths and hospitalisations.
@SickKidsGlobal#globalchildhealth #MSFscidays
The crisis in Sudan is a health catastrophe that the world cannot afford to ignore. Yet, the global response has been gravely inadequate.
Our latest Editorial calls for sustained global commitment & attention to safeguard health in Sudan.
Read now: https://t.co/617gwOcFru
🚨MSF Medical Directors made a united call at #MSFSciDay2025 and in the @LancetGH: research is not optional—it's essential to humanitarian action.
🌍In a world of evolving crises, evidence must guide how we care, respond, and stay accountable.
🔗Read more: https://t.co/MBnT2d3JCR
#MSFsci #LondonCalling #MSFScientificDay #GlobalHealth
🚨Now at #MSFsci: Prof. Kathryn Maitland from @imperialcollege presenting GASTROSAM — a game-changing protocol for treating malnourished & dehydrated children in resource-limited settings 💧
📊A new approach designed to save lives by improving fluid management where standard guidelines fall short.
#MSFScientificDay #GlobalHealth #Malnutrition #ChildHealth #Innovation #HumanitarianHealth #OperationalResearch
🎤 Panel now live at #MSFsci: tackling persistent barriers to addressing malnutrition in humanitarian settings.
Diverse voices across sectors:
🧠 Claire Bossard from @Epicentre_MSF
📉 Mario-David Barbagallo from @MSF
🩺Dr. Jobayer Chisti from @icddr_b
💧 Prof. Kathryn Maitland from @imperialcollege
🏥Erik Munroe from @CIFFchild
🌍 Kirrily de Polnay from @UNICEF
#MSFScientificDay #Nutrition #GlobalHealth #HumanitarianHealth
Hidden in the shadows of poverty and neglect, Noma silently destroys the faces and futures of the world’s most vulnerable children.
It begins as a simple gum infection, but if left untreated, it kills 9 out of 10 children, most of them between the ages of 2 and 6, within days.
#EndNomaNaija
Despite its severity, Noma has been largely invisible on the global health agenda for decades. However, in December 2023, the @WHO officially added Noma to the list of Neglected Tropical Diseases.
WHO's NTD recognition is:
➡️Expected to drive research and data efforts
➡️May strengthen early detection and response
➡️Could prompt action on root social drivers
Read this publication on PLOS: https://t.co/QbuVEUQPhN
📣New thesis now live in Research Online!
Short, effective and safe all-oral treatment for rifampicin resistant tuberculosis. The TB-PRACTECAL trial and its drugs pharmacokinetics by @docwak77
https://t.co/PrHSZ5xrm0
#thesis#tuberculosis#OpenAccessNew#PhD
5/
Today, improved treatments and better medical tools are available for tackling this deadly infectious disease. What we need now is bold, collective action to deliver them—at scale and with urgency. #EndTB#MDRTB
1/
Glad to have been part of an invigorating 3-day workshop to accelerate the uptake of new WHO TB policies across the WHO European region. Experts from 12 countries joined in—national TB programmes, labs, implementers, donors, civil society & technical partners. 🧵
4/
Despite strong health systems , over 65,000 new cases of MDR/RR-TB were reported in the European region in 2023. This is a wake-up call. We can't let outdated approaches hold back progress when shorter, effective people-centered treatments and practices are within reach.
This #WorldPneumoniaDay2024, we’re highlighting one of the leading cause of death amongst children worldwide - Pneumococcal #pneumonia.
By mass vaccinating children under 5 with pneumococcal conjugate vaccine, we can provide a lot of protection to the community at large 💉.
Stay tuned, we’ll be delving into this & more throughout the day.
#vaccineswork #PneumoniaAwareness
Continuous glucose monitoring (CGM) is one of the most powerful components of diabetes self-management. However, there are ongoing inequalities in accessing CGM technologies.
A @TheLancetEndo Viewpoint looks at advancements in CGM & current inequalities: https://t.co/QS8M7CE6xe
Promising results shown when co-treating multidrug-resistant #TB (MDR-TB) alongside #HepatitisC virus (HCV) infection in a small cohort across Belarus🇧🇾, Uzbekistan🇺🇿 & South Africa🇿🇦, showcasing the potential benefits of integrating HCV care into MDR-TB management.
➡️https://t.co/Ipj6O7Dr2A
#MSF